首页> 外文期刊>Medicine. >Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
【24h】

Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial

机译:中风体积变异引导液治疗降低患有激进膀胱切除术期间的血液损失和输血要求的疗效和安全性:随机临床试验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Radical cystectomy, which is performed to treat muscle-invasive bladder tumors, is among the most difficult urological surgical procedures and puts patients at risk of intraoperative blood loss and transfusion. Fluid management via stroke volume variation (SVV) is associated with reduced intraoperative blood loss. Therefore, we evaluated the efficacy and safety of SVV-guided fluid therapy for reducing blood loss and transfusion requirements in patients undergoing radical cystectomy.This study included 48 patients who underwent radical cystectomy, and these patients were randomly allocated to the control group and maintained at <10% SVV (n=24) or allocated to the trial group and maintained at 10% to 20% SVV (n=24). The primary endpoints were comparisons of the amounts of intraoperative blood loss and transfused red blood cells (RBCs) between the control and trial groups during radical cystectomy. Intraoperative blood loss was evaluated through the estimated blood loss and estimated red cell mass loss. The secondary endpoints were comparisons of the postoperative outcomes between groups.A total of 46 patients were included in the final analysis: 23 patients in the control group and 23 patients in the trial group. The SVV values in the trial group were significantly higher than in the control group. Estimated blood loss, estimated red cell mass loss, and RBC transfusion requirements in the trial group were significantly lower than in the control group (734.3321.5mL vs 1096.5 +/- 623.9mL, P=0.019; 274.1 +/- 207.8mL vs 553.1 +/- 298.7mL, P<0.001; 0.5 +/- 0.8 units vs 1.9 +/- 2.2 units, P=0.005). There were no significant differences in postoperative outcomes between the two groups.SVV-guided fluid therapy (SVV maintained at 10%-20%) can reduce blood loss and transfusion requirements in patients undergoing radical cystectomy without resulting in adverse outcomes. These findings provide useful information for optimal fluid management during radical cystectomy.
机译:进行治疗肌肉侵入性膀胱肿瘤的自由基膀胱切除术是最难的泌尿外科手术手术,并使患者患有术中失血和输血的风险。通过行程体积变异(SVV)的流体管理与降低的术中失血相关。因此,我们评估了SVV引导的流体治疗的疗效和安全性,用于降低受激菌膀胱切除术的患者的血液损失和输血要求。本研究包括48名接受激进膀胱切除术的患者,这些患者随机分配给对照组并维持<10%SVV(n = 24)或分配给试验组,并保持10%至20%SVV(n = 24)。主要终点是在自由基膀胱切除术期间对照和试验组之间的术中失血量和转染的红细胞(RBC)的比较。通过估计的血液损失和估计的红细胞大量损失评估术中失血。次要终点是术后术后结果的比较。总共46名患者的最终分析中包括:23例患者在试验组中进行4例患者。试验组中的SVV值显着高于对照组。试验组中估计的血液损失,估计的红细胞质量损失和RBC输血要求显着低于对照组(734.3321.5ml vs 1096.5 +/- 623.9ml,P = 0.019; 274.1 +/- 207.8ml VS 553.1 +/- 298.7ml,p <0.001; 0.5 +/- 0.8单位与1.9 +/- 2.2单位,p = 0.005)。两组之间的术后结果没有显着差异。(SVV导液治疗)(SVV维持在10%-20%)可以降低经过根治性膀胱切除术的患者的血液损失和输血要求,而不会导致不良结果。这些发现提供了在激进膀胱切除术期间最佳流体管理的有用信息。

著录项

  • 来源
    《Medicine.》 |2016年第19期|共9页
  • 作者单位

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

    Univ Ulsan Coll Med Asan Med Ctr Dept Anesthesiol &

    Pain Med 88 Olymp Ro 43 Gil Seoul South;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号